# Trima Pharmaceutical Products
> Israeli pharmaceutical company.

Basic company reference. Business areas, products and practical answers have not been added.

- Canonical entity: https://directory.readyscan.ai/entities/trima-pharmaceutical-products-q106620053
- Website listed in the source snapshot: https://www.trima.co.il/
- Category: [Pharmaceuticals](https://directory.readyscan.ai/directory/pharmaceuticals)
- Machine record: https://directory.readyscan.ai/discovery/entities/trima-pharmaceutical-products-q106620053.json
- Material fingerprint: fnv1a64:1b702ad5fb62e907
- Entity revision: fnv1a64:9eda4fa16a95c50e
- Published: 2026-07-29
- Modified: 2026-07-29

## More in Pharmaceuticals
- [Panaxia](https://directory.readyscan.ai/entities/panaxia-q108057168) — Israeli pharmaceutical company.
- [Protalix Biotherapeutics Inc](https://directory.readyscan.ai/entities/protalix-biotherapeutics-inc-q7251166) — Israeli pharmaceutical company.
- [Teva Pharmaceutical Industries Ltd.](https://directory.readyscan.ai/entities/teva-pharmaceutical-industries-ltd-q898750) — Israeli pharmaceutical company.

## Company sources
- [Trima Pharmaceutical Products — Wikidata Q106620053](https://www.wikidata.org/wiki/Special:EntityData/Q106620053.json?revision=2043530888) — Wikidata

## Data access & reuse
- [Wikidata data access](https://www.wikidata.org/wiki/Help:Data_access) — Wikidata
- [Wikidata reuse permission](https://www.wikidata.org/wiki/Wikidata:Licensing) — Wikidata
- [CC0 1.0 Universal](https://creativecommons.org/publicdomain/zero/1.0/) — Wikidata

## Continue reading
- Discover the bounded graph: https://readyscan.ai/api/v1/ai-search/discovery
- Retrieve this entity evidence: https://readyscan.ai/api/v1/ai-search/entities/trima-pharmaceutical-products-q106620053/evidence

## Publication boundary
- This public-sourced record brings together company information and its sources. It is not an owner-managed profile.
- Publication does not guarantee crawling, indexing, training inclusion, citation, recommendation, referral, or revenue.